HCM Acquisition Corp $HCMA Stock Position Lifted by Radcliffe Capital Management L.P.

Radcliffe Capital Management L.P. boosted its stake in HCM Acquisition Corp (NASDAQ:HCMA) by 21.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 700,000 shares of the company’s stock after buying an additional 125,000 shares during the quarter. HCM Acquisition makes up about 0.4% of Radcliffe Capital Management L.P.’s holdings, making the stock its 25th biggest position. Radcliffe Capital Management L.P. owned approximately 4.95% of HCM Acquisition worth $7,028,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. Meteora Capital LLC purchased a new position in shares of HCM Acquisition during the 3rd quarter valued at $16,587,000. Verition Fund Management LLC purchased a new stake in shares of HCM Acquisition during the third quarter worth $11,617,000. Linden Advisors LP acquired a new stake in HCM Acquisition during the third quarter valued at $10,100,000. Highbridge Capital Management LLC acquired a new stake in HCM Acquisition during the third quarter valued at $10,100,000. Finally, MMCAP International Inc. SPC purchased a new position in HCM Acquisition in the fourth quarter valued at about $10,040,000. Institutional investors and hedge funds own 11.79% of the company’s stock.

HCM Acquisition Stock Performance

NASDAQ HCMA opened at $10.28 on Wednesday. HCM Acquisition Corp has a 12-month low of $10.03 and a 12-month high of $10.49. The company has a 50 day moving average price of $10.18 and a two-hundred day moving average price of $10.14.

HCM Acquisition (NASDAQ:HCMA) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.05 EPS for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised HCM Acquisition from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 1st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, HCM Acquisition presently has a consensus rating of “Sell”.

HCM Acquisition Company Profile

HCM Acquisition Corp. is a Delaware‐incorporated special purpose acquisition company (SPAC) that was formed to identify and complete a business combination with one or more target businesses. The company raised capital through its initial public offering and is listed on the Nasdaq under the ticker HCMA. As a blank check vehicle, HCM Acquisition holds its funds in trust until it consummates a qualifying merger, share exchange, asset acquisition or other business combination.

The SPAC is sponsored by affiliates of Healthcare Capital Management LLC, a Los Angeles‐based investment firm with experience in healthcare and life sciences investing.